IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1893
Positioning
Market Dominance
Wholesale Trade
Wholesale
$8.0B
Stanley M. Bergman
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics. The Health Care Distribution segment offers dental products, including infection-control products, X-ray supplies and equipment. The Technology and Value-Added Services segment offers software, technology and other value-added services.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = HSIC ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$ITRN Ituran Location & Control Ltd. | 74 | 95 | 97 | 62 | - | - | 30.4% | 17.5% | 47.8% | 21.2% | 16.8% | 5.1% | 5.1% | 0.0x | $612M | VS | |
$COR Cencora, Inc. | 70 | 84 | 77 | 70 | 21.1x | 11.8x | 123.8% | 2.2% | 3.6% | 0.8% | 0.5% | 9.3% | 0.7% | 508.0x | $60.5B | VS | |
$CENT CENTRAL GARDEN & PET CO | 70 | 84 | 95 | 48 | 5.9x | 3.5x | 10.4% | 4.6% | 31.9% | 8.0% | 5.2% | -2.2% | 0.0% | 75.0x | $2.1B | VS | |
$SNX TD SYNNEX CORP | 67 | 80 | 93 | 57 | 13.5x | 6.2x | 10.0% | 2.6% | 7.0% | 2.3% | 1.3% | 6.9% | 1.2% | 55.0x | $12.4B | VS | |
$HLF HERBALIFE LTD. | 65 | 60 | 75 | 96 | 5.0x | 1.4x | -32.4% | 6.3% | 77.7% | 9.9% | 3.4% | 2.7% | 0.0% | - | $870M | VS | |
$GIC GLOBAL INDUSTRIAL Co | 65 | 82 | 60 | 62 | 18.7x | 12.5x | 24.0% | 12.5% | 35.6% | 7.4% | 5.3% | 3.3% | 2.8% | 0.0x | $1.4B | VS | |
$JXG JX Luxventure Group Inc. | 63 | 84 | 75 | 88 | - | - | 20.4% | 11.9% | 16.8% | 7.8% | 6.2% | 56.5% | 0.0% | 22.0x | $6M | VS | |
$FERG Ferguson Enterprises Inc. /DE/ | 63 | 74 | 48 | 67 | 21.4x | 14.3x | 39.4% | 12.6% | 30.7% | 9.4% | 7.0% | 5.1% | 1.3% | 68.0x | $48.9B | VS | |
$SYY SYSCO CORP | 60 | 68 | 49 | 65 | 22.7x | 9.2x | 89.9% | 5.9% | 18.3% | 3.3% | 1.9% | 3.0% | 2.9% | 595.0x | $35.3B | VS | |
$DXPE DXP ENTERPRISES INC | 60 | 58 | 55 | 79 | 21.6x | 8.5x | 25.1% | 6.2% | 31.4% | 8.5% | 4.2% | 8.6% | 0.0% | 128.0x | $1.9B | VS | |
$HSIC HENRY SCHEIN INC | 51 | 42 | 52 | 54 | 22.6x | 10.3x | 10.3% | 3.7% | 31.2% | 5.0% | 3.2% | 6.5% | 0.0% | 154.0x | $8.0B | ||
| SECTOR BENCH | - | - | - | - | - | 19.1x | 8.2x | 8.6% | 2.7% | 22.5% | 3.3% | 1.4% | 3.3% | 0.3% | 0.5x | - | REF |
HENRY SCHEIN INC (HSIC) receives a "Hold" rating with a composite score of 50.8/100. It ranks #1893 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Stanley M. Bergman
Chief Executive Officer
Labor Force
22,000
42
37
84
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for HSIC
In-line with peers — no strong momentum signal
Fair valuation relative to peers
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Wholesale Trade sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for HSIC.
View All RatingsMaterial decline in asset turnover efficiency detected
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 42 | 40 | +2NEUTRAL |
| MOMENTUM | 54 | 58 | -4NEUTRAL |
| VALUATION | 52 | 60 | -8DRAG |
| INVESTMENT | 37 | 68 | -31DRAG |
| STABILITY | 84 | 93 | -9DRAG |
| SHORT INT | 38 | 31 | +7ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 4.0% vs WACC 7.4% (spread -3.5%)
GM 31% vs sector 22%, OM 5% vs sector 3%
Capital turnover 1.04x
Rev growth 6%, 10yr history
Interest coverage 4.3x, Net debt/EBITDA 13.9x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns HENRY SCHEIN INC a Hold rating, with a composite score of 50.8/100 and 3 out of 5 stars. Ranked #1893 of 7,333 stocks, HSIC presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
HSIC's quality score of 42/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of 10.3% (sector avg: 8.6%), gross margins of 31.2% (sector avg: 22.5%), net margins of 3.2% (sector avg: 1.4%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
HSIC's value score of 52/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 22.57x, an EV/EBITDA of 10.35x, a P/B ratio of 2.33x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
HENRY SCHEIN INC's investment score of 37/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 6.5% vs. a sector average of 3.3% and a return on assets of 3.7% (sector: 2.7%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
HSIC demonstrates moderate momentum with a score of 54/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at 6.5% year-over-year, while a beta of 0.59 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
HSIC shows good financial stability with a score of 84/100. Key stability metrics include a beta of 0.59 and a debt-to-equity ratio of 154.00x (sector avg: 0.5x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
HENRY SCHEIN INC's short interest score of 38/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 154.00x). At $8.0B (mid-cap), HSIC carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
HENRY SCHEIN INC is a mid-cap company in the Wholesale Trade sector, ranked #41 of 50 in its sector (18th percentile) and #1893 of 7,333 overall (74th percentile). Key comparisons include ROE of 10.3% exceeding the 8.6% sector median and operating margins of 5.0% above the 3.3% sector average. This bottom-quartile standing highlights significant competitive headwinds within the Wholesale Trade space.
While HSIC currently exhibits a HOLD profile, superior opportunities exist within the WHOLESALE TRADE sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Wholesale Trade Alpha →Quant Factor Profile
Key factor gap
Stability (84) vs Investment (37) — closing this gap could shift the rating.
RANK #41 OF 50 IN CONSUMER STAPLES
EV/EBITDA 27% ABOVE SECTOR MEDIAN
ROE 20% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 39% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 27, 2025 (Q2 FY2025)
We rate HENRY SCHEIN INC (HSIC) as a Hold with a composite score of 50.8/100 at a current price of $83.33. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in stability (84th percentile) and momentum (54th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (37th percentile) and quality (42th percentile) tempers our overall conviction. We assign a No Moat rating (37/100), Medium uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
HENRY SCHEIN INC holds a lower-quartile position (#41 of 50) within the Wholesale Trade sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 50.8/100 places it at rank #1893 in our full 7,333-stock universe. At $8.0B in market capitalization, HENRY SCHEIN INC is a mid-cap player in the Wholesale Trade space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 6%, though momentum at the 54th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 31% (+8.8pp vs sector) narrow to operating margins of 5% (+1.8pp vs sector) and net margins of 3.2%, yielding a gross-to-net conversion rate of 10%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $83.33, HENRY SCHEIN INC is trading near fair value based on current fundamentals. Our value factor score of 52/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 22.6x (roughly in line with the sector median of 19.1x), EV/EBITDA of 10.3x (at a premium), P/B of 2.3x, P/S of 0.7x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis finds only partially justified by current fundamentals.
The stock may offer contrarian value if near-term headwinds prove transitory — the current weakness in factor scores may reverse if business fundamentals stabilize.
Elevated leverage (154% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
We assign a Medium uncertainty rating to HENRY SCHEIN INC. The stock presents a balanced risk profile: significant leverage (154% debt-to-equity) and low beta of 0.59 — while defensive, this may indicate limited upside participation in bull markets. While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: significant leverage (154% debt-to-equity); low beta of 0.59 — while defensive, this may indicate limited upside participation in bull markets; the combination of leverage (154% D/E) and thin margins (3.2% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 84th percentile and quality factor at the 42th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: above-average stability (84th percentile) suggests predictable business dynamics. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate HENRY SCHEIN INC's capital allocation as Poor. Key concerns include elevated leverage (154% D/E). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — HENRY SCHEIN INC significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, HENRY SCHEIN INC receives a Hold rating with a composite score of 50.8/100 (rank #1893 of 7,333). Our quantitative framework assigns a No Moat (37/100, trend: stable), Medium uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 54/100.
Our analysis supports a neutral stance on HENRY SCHEIN INC. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign HENRY SCHEIN INC a meaningful economic moat, scoring 37/100 on our composite assessment. The ROIC-WACC spread of -3.5% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 14.3/20.
The strongest moat sources are margin superiority (14.3/20) and growth durability (7.8/20). GM 31% vs sector 22%, OM 5% vs sector 3%. Rev growth 6%, 10yr history. These pillars form the core of HENRY SCHEIN INC's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (2.1/20) and economic value creation (6.1/20). Capital turnover 1.04x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect HENRY SCHEIN INC's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include moderate revenue growth of 6%. The margin cascade from 31% gross to 5% operating to 3.2% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 42th percentile.
The margin profile shows gross margins of 31%, operating margins of 5%, net margins of 3.2%. Return metrics include ROE of 10.3% and ROA of 3.7%. Relative to the Wholesale Trade sector, gross margins are 8.8 percentage points above the sector median of 22%, and ROE of 10.3% compares to a sector median of 8.6%.
The balance sheet reflects high leverage with D/E of 154%, which may limit financial flexibility, revenue growth of 6%. The sector median D/E is 1%, putting HENRY SCHEIN INC at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.

Zuckerman Investment Group increased its Henry Schein stake by 72,040 shares in Q3, bringing its position to 281,339 shares valued at $18.67 million. The purchase reflects confidence in Henry Schein's improving fundamentals, including 5% revenue growth to $3.3 billion, 13% non-GAAP EPS growth to $1.38, and a new $200 million efficiency plan. The company also repurchased $229 million in stock during the quarter.
Henry Schein (HSIC) Q4 2025 earnings call recap: CEO transition, record sales growth, 2026 EPS guidance, margins, buybacks and risks—read now.

Healthcare solutions distributor Henry Schein reported Q2 2025 financial results with mixed performance, experiencing revenue growth but declining profitability due to margin pressures in dental operations and increased restructuring costs.
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) jumped 4.8% in the afternoon session after the company reported decent fourth-quarter 2025 financial results where revenue surpassed Wall Street's expectations, but earnings fell short. The dental and medical products distributor posted quarterly sales of $3.44 billion, a 7.7% increase year on year that beat analyst forecasts. Investors appeared to focus on the strong top-line performance, which was supported by a 4.9% rise
Henry Schein (NASDAQ:HSIC) reported fourth-quarter 2025 results on Feb. 24, 2026, highlighting what management described as its “highest sales growth in 15 quarters,” alongside progress on its 2025–2027 BOLD+1 strategic plan and an update to its leadership transition. Leadership transition and stra
Above 50MA
37.18%
Net New Highs
+51081